PSCA

PSCA

PSCA Overview

Molecule Name
Prostate stem cell antigen
Synonyms
PSCA,UNQ206,PRO232
Drug Development Progress
Drugs in Clinical Trials4
Approved Drugs0
Highest Development StagePhase 1 Clinical
Target Synonym
Prostate stem cell antigen,UNQ206/PRO232,PSCA,PRO232
Background
The Prostate stem cell antigen (PSCA) is a glycosylphosphatidylinositol (GPI)-anchored protein, plays an important role in tumorigenesis. The prostate stem cell antigen (PSCA) gene, which encodes a prostate-specific antigen (PSA), was identified as a gene involved in cell adhesion and proliferation. PSCA may be involved in the regulation of cell proliferation. Has a cell-proliferation inhibition activity in vitro. May act as a modulator of nicotinic acetylcholine receptors (nAChRs) activity. In vitro inhibits nicotine-induced signaling probably implicating alpha-3:beta-2- or alpha-7-containing nAChRs.

PSCA Product List

Species
  • Human(4)
  • Mouse(1)
Tag
  • His Tag(3)
  • His Tag & Avi Tag(2)
Host
  • HEK293(5)
Conjugate
  • Biotin-labeled(2)
  • AF488 Labeled(1)
  • PE Labeled(1)
  • Unconjugated(1)
Grade
  • RUO(5)
Low Endotoxin
  • No(5)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
PSCA
Human PSCA Protein, His Tag
Human
HEK293
SDS-PAGE
ELISAFlow

$470.00

100ug
PSCA
HOTAvitag
PSA-H82E3
Biotinylated Human PSCA Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISAFlow

$415.00

25ug
PSCA
Alexa Fluor™ 488-Labeled Human PSCA Protein, His Tag (Site-specific conjugation)
Human
HEK293
Flow

$415.00

25tests
PSCA
PE-Labeled Human PSCA Protein, His Tag (Site-specific conjugation)
Human
HEK293
Flow

$415.00

25tests
PSCA
Avitag
PSA-M82Ea
Biotinylated Mouse PSCA Protein, His,Avitag™ (MALS verified)
Mouse
HEK293
MALS

$710.00

100ug
You Have Viewed 1-5 Of 5 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes (City of Hope Medical Center)Phase 1 ClinicalCity Of Hope National Medical Center
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Details
124-iodine-labeled PSCA targeting minibody (ImaginAb)Phase 1 ClinicalUniversity Of California At Los Angeles
Pancreatic Neoplasms; Prostatic Neoplasms; Urinary Bladder Neoplasms
Details
anti-PSMA/anti-PSCA CAR T-cell therapy PD-1 silent (Shanghai Unicar-Therapy Bio-medicine)Phase 1 ClinicalShanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Hormone-Resistant Prostate Neoplasms
Details
MB-104MB-104; MB-105; MB-104 CS1 CAR; MB-105 PSCA CARPhase 1 ClinicalCity Of Hope National Medical Center
Glioblastoma; Multiple Myeloma; Pancreatic Neoplasms; Prostatic Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms
Details
Customer Reviews